Trial intelligence / Profile preview

rhBMP-2 plus cannulated compression screws for femoral neck fracture in young adults

ChiCTR2300072199Phase 4Not yet recruiting

Sponsor
The Third Hospital of Hebei Medical University
Start
Jul 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of dibotermin alfa in Neck Of Femur Fracture (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoints: Time of fracture union and Surgical complications. Planned start Jul 2023; status: not yet recruiting.

02

Drugs

dibotermin alfa
03

Conditions

Neck Of Femur Fracture

Beyond the preview

Go deeper on ChiCTR2300072199.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300072199.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call